Search for: "Church v. Pfizer Inc." Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2014, 5:56 am
* LDS Church and Mormon fundamentalist group set for Canadian clash over concurrent use The second Canadian tale of the week concerns a cross-border trade mark fight between the Church of Jesus Christ of Latter-day Saints and Church of Jesus Christ of the Latter Day Saints Inc. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging… [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent… [read post]
9 Mar 2010, 12:20 am
Though the justices almost never reveal their reasons for recusal, this one is almost certainly based on Roberts' stock ownership in Pfizer, which also became an issue in last year's landmark pre-emption case Wyeth v. [read post]